3min chapter

Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

CHAPTER

Is This an Uncomplicated UTI Agent?

Eagle one is in gonorrhea. They're looking at female patients age 12 and older with clinic clinically suspected uncomplicated UTIs. And they're randomizing them to either Jepo 1500 twice a day for five days by mouth or an extra few and tone 100 milligrams by mouth twice a dayfor five days. Their primary efficacy composite will be therapeutic response at test of cure around days 10 to 13, then their secondary outcomes will be safety and other things that as you would expect.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode